GSK agrees to pay $2.2bn to settle US Zantac cancer cases. The settlements cover 93% of claims, including a whistleblower complaint. GSK denies wrongdoing, removing financial risks from ongoing litigation.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing